1) Do you think ESC, derived relatively fresh from the germline could provide the reference?
Yes, I think ESCs would be more than sufficient for the purposes of reaching escape velocity. However, more direct control will be required eventually, i.e. chromosome synthesis, and would obviously be advantageous for many other reasons.
2) Are you literally referring to all cells of the body, including HTT (high turnover tissues) in the course of a therapeutic life-extension scheme that involves massive cell replacement?
Since the HTT are being turned over quickly, secondary aging will not be a major problem in them. However, in the earlier stages of SENS use, stress on the body will undoubtedly be high, and any and all ways of reducing that stress by reducing the frequency of cell replacement or otherwise, will be desireable. Also, if we need to include a payload of genetic information for the chemotherapy dependencies, we might as well include as many other advantageous genes as we can.
3) If you think HTT may do without certain augmentations (e.g. allotopic expression), what do you think are the prospects of turning some of those tissues which are presently LTT into HTT (or at least into medium-TT), in the face of recent advances in ESC therapy of heart and brain?
LTT will have to be replaced at some rate, and the ideal rate may be that of 'mediam-TT'. I have a distaste for making us dependent on frequent tissue replacement beyond what its absolutely necessary. That may just be a personal bias, but there certainly are risks involved in frequent large scale tissue replacement.
4) Do you think some MEPs can be removed by means that are not genes, e.g. protein therapy for catabolism, guided ultrasound for cell ablation, ect. and do you think these possibilities can be more efficient?
MEPs could be treated by other means, and in the CNS they initially will have to be. As for which strategy is more efficient, that would depend on how the specific treatments are designed. I think protein therapy and other such technologies may be complementary to internal MEP removal, but generally couldn't be as efficient as having the cells clean themselves up. I see protein therapy as an approximation to internal MEP removal.
It is nice to see the similarity to my own proposal. Do you have some concrete systems in mind, especially as for "dependencies on certain chemicals?"
Unfortunately I don't have any specifics in mind, it was a purely theoretical exercise. I was impressed with your proposal, but I haven't commented on it since I don't know enough about the subject to say anything useful. I bought two books on stem cell biology and tissue therapy from the New York Academy of Science (Annals volume 961 and 944) and plan to read them after exams (they definitely don't teach this stuff in undergrad). Then hopefully I can be of some help, perhaps we'll collaberate in the future